Cargando…
Deep venous thrombosis in the antenatal period in a large cohort of pregnancies from western India
BACKGROUND: Deep venous thrombosis (DVT) is an important complication in the peripartal and postpartal period. METHODS: We followed up prospectively the prevalence of DVT in 34720 prenatal mothers between June 2002 and July 2006 attending the antenatal clinics of two major hospitals in Mumbai, India...
Autores principales: | , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1950495/ https://www.ncbi.nlm.nih.gov/pubmed/17610719 http://dx.doi.org/10.1186/1477-9560-5-9 |
_version_ | 1782134548396507136 |
---|---|
author | Vora, Sonal Ghosh, Kanjaksha Shetty, Shrimati Salvi, Vinita Satoskar, Purnima |
author_facet | Vora, Sonal Ghosh, Kanjaksha Shetty, Shrimati Salvi, Vinita Satoskar, Purnima |
author_sort | Vora, Sonal |
collection | PubMed |
description | BACKGROUND: Deep venous thrombosis (DVT) is an important complication in the peripartal and postpartal period. METHODS: We followed up prospectively the prevalence of DVT in 34720 prenatal mothers between June 2002 and July 2006 attending the antenatal clinics of two major hospitals in Mumbai, India. Thirty two women (0.1%) presented for the first time with symptomatic DVT i.e. 17 in the first trimester, 6 in the second and 9 in the third trimester of pregnancy. Nine had history of fetal loss while in the remaining twenty three there was no history of fetal loss. RESULTS: The evaluation of both acquired and heritable thrombophilia showed a conglomeration of thrombophilia in this group when compared to 100 normal pregnant women who have given birth to at least one healthy baby with no history of fetal death, DVT or other obstetrical complications. The relative risks for all the antiphospholipid antibodies (APA) studied i.e lupus anticoagulant (LA), IgG/IgM antibodies for cardiolipin (ACA), β2 glycoprotein 1 (β2 GP 1) and annexin V were significantly higher in women with pregnancy associated DVT (RR 7.4 95% CI 4.3–11.3 P < 0.05). Among the genetic thrombophilia markers studied, Protein S (PS) deficiency was the strongest risk factor (RR 5.00 95% CI 3.02–5.00 P < 0.05) followed by factor V Leiden (FVL) mutation (RR 4.57 95% CI 2.23–4.57 P < 0.05) and PAI 4G/4G homozygosity (RR 3.24 95% CI 1.85–5.12 P < 0.05). Protein C (PC) and endothelial protein C receptor (EPCR) 23 bp insertion polymorphism was also increased in the patient group as compared to controls but the difference was not statistically significant. The MTHFR C677T, fibrinogen gene β448 Arg/Lys polymorphisms were not significantly different from the normal controls, while antithrombin III (AT III) deficiency and PT G20210A polymorphism were absent in both controls and patients. Two or more risk factors were present in 22 out of 32 cases (68.75%). CONCLUSION: We conclude that the prevalence of DVT in India is more or less similar to other reports published and both acquired and heritable thrombophilia show strong association with DVT associated with pregnancy. |
format | Text |
id | pubmed-1950495 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2007 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-19504952007-08-22 Deep venous thrombosis in the antenatal period in a large cohort of pregnancies from western India Vora, Sonal Ghosh, Kanjaksha Shetty, Shrimati Salvi, Vinita Satoskar, Purnima Thromb J Original Clinical Investigation BACKGROUND: Deep venous thrombosis (DVT) is an important complication in the peripartal and postpartal period. METHODS: We followed up prospectively the prevalence of DVT in 34720 prenatal mothers between June 2002 and July 2006 attending the antenatal clinics of two major hospitals in Mumbai, India. Thirty two women (0.1%) presented for the first time with symptomatic DVT i.e. 17 in the first trimester, 6 in the second and 9 in the third trimester of pregnancy. Nine had history of fetal loss while in the remaining twenty three there was no history of fetal loss. RESULTS: The evaluation of both acquired and heritable thrombophilia showed a conglomeration of thrombophilia in this group when compared to 100 normal pregnant women who have given birth to at least one healthy baby with no history of fetal death, DVT or other obstetrical complications. The relative risks for all the antiphospholipid antibodies (APA) studied i.e lupus anticoagulant (LA), IgG/IgM antibodies for cardiolipin (ACA), β2 glycoprotein 1 (β2 GP 1) and annexin V were significantly higher in women with pregnancy associated DVT (RR 7.4 95% CI 4.3–11.3 P < 0.05). Among the genetic thrombophilia markers studied, Protein S (PS) deficiency was the strongest risk factor (RR 5.00 95% CI 3.02–5.00 P < 0.05) followed by factor V Leiden (FVL) mutation (RR 4.57 95% CI 2.23–4.57 P < 0.05) and PAI 4G/4G homozygosity (RR 3.24 95% CI 1.85–5.12 P < 0.05). Protein C (PC) and endothelial protein C receptor (EPCR) 23 bp insertion polymorphism was also increased in the patient group as compared to controls but the difference was not statistically significant. The MTHFR C677T, fibrinogen gene β448 Arg/Lys polymorphisms were not significantly different from the normal controls, while antithrombin III (AT III) deficiency and PT G20210A polymorphism were absent in both controls and patients. Two or more risk factors were present in 22 out of 32 cases (68.75%). CONCLUSION: We conclude that the prevalence of DVT in India is more or less similar to other reports published and both acquired and heritable thrombophilia show strong association with DVT associated with pregnancy. BioMed Central 2007-07-04 /pmc/articles/PMC1950495/ /pubmed/17610719 http://dx.doi.org/10.1186/1477-9560-5-9 Text en Copyright © 2007 Vora et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Clinical Investigation Vora, Sonal Ghosh, Kanjaksha Shetty, Shrimati Salvi, Vinita Satoskar, Purnima Deep venous thrombosis in the antenatal period in a large cohort of pregnancies from western India |
title | Deep venous thrombosis in the antenatal period in a large cohort of pregnancies from western India |
title_full | Deep venous thrombosis in the antenatal period in a large cohort of pregnancies from western India |
title_fullStr | Deep venous thrombosis in the antenatal period in a large cohort of pregnancies from western India |
title_full_unstemmed | Deep venous thrombosis in the antenatal period in a large cohort of pregnancies from western India |
title_short | Deep venous thrombosis in the antenatal period in a large cohort of pregnancies from western India |
title_sort | deep venous thrombosis in the antenatal period in a large cohort of pregnancies from western india |
topic | Original Clinical Investigation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1950495/ https://www.ncbi.nlm.nih.gov/pubmed/17610719 http://dx.doi.org/10.1186/1477-9560-5-9 |
work_keys_str_mv | AT vorasonal deepvenousthrombosisintheantenatalperiodinalargecohortofpregnanciesfromwesternindia AT ghoshkanjaksha deepvenousthrombosisintheantenatalperiodinalargecohortofpregnanciesfromwesternindia AT shettyshrimati deepvenousthrombosisintheantenatalperiodinalargecohortofpregnanciesfromwesternindia AT salvivinita deepvenousthrombosisintheantenatalperiodinalargecohortofpregnanciesfromwesternindia AT satoskarpurnima deepvenousthrombosisintheantenatalperiodinalargecohortofpregnanciesfromwesternindia |